Bristol-Myers Squibb Company (BMY) Stock Overview
Explore Bristol-Myers Squibb Company’s financial performance, market position, analyst ratings, and future outlook.
Bristol-Myers Squibb Company (BMY)
Key Financials
Key Financials
Market Cap
129.9B
P/E Ratio
13.95
EPS (TTM)
$5.93
ROE
0.47%
BMY Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of Bristol-Myers Squibb Company (NYSE: BMY) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Bristol-Myers Squibb Company's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of BMY on the NYSE shows an RSI of 41.27, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $56.05 for the NYSE listing.
Key metrics behind Bristol-Myers Squibb Company's NYSE-traded stock include a P/E ratio of 13.95 and a market capitalization of 129.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of BMY on the NYSE.